These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8226821)

  • 1. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.
    Kong H; Raynor K; Yasuda K; Moe ST; Portoghese PS; Bell GI; Reisine T
    J Biol Chem; 1993 Nov; 268(31):23055-8. PubMed ID: 8226821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis of the mouse delta opioid receptor converts (-)-buprenorphine from a partial agonist to an antagonist.
    Bot G; Blake AD; Li S; Reisine T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):283-90. PubMed ID: 9435189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site.
    Befort K; Tabbara L; Bausch S; Chavkin C; Evans C; Kieffer B
    Mol Pharmacol; 1996 Feb; 49(2):216-23. PubMed ID: 8632752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
    Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.
    Bot G; Blake AD; Li S; Reisine T
    Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
    Wang WW; Shahrestanifar M; Jin J; Howells RD
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
    Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
    J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
    Cavalli A; Babey AM; Loh HH
    Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H][D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-tert-butyl),Leu5]enkephalyl-Thr6(O-tert-butyl). Two new enkephalin analogs with both a good selectivity and a high affinity toward delta-opioid binding sites.
    Delay-Goyet P; Seguin C; Gacel G; Roques BP
    J Biol Chem; 1988 Mar; 263(9):4124-30. PubMed ID: 2831220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of regions of the opioid receptor involved in selective agonist binding.
    Fukuda K; Kato S; Mori K
    J Biol Chem; 1995 Mar; 270(12):6702-9. PubMed ID: 7896813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the delta- and mu-opioid receptors.
    Fukuda K; Terasako K; Kato S; Mori K
    FEBS Lett; 1995 Oct; 373(2):177-81. PubMed ID: 7589460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.
    Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
    Peptides; 1993; 14(5):893-907. PubMed ID: 8284266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
    Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
    Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
    J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
    Sofuoglu M; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.